Ondansetron Injection
Product Images NDC 55154-2876

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-2876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7d1c9756 013d 4888 Addf 7670da77b884 00

7d1c9756 013d 4888 Addf 7670da77b884 00
Label for Ondansetron Injection USP 4 mg/2 mL (2 mg/mL) in 5 x 2 mL single dose vials, for IV or IM injection. The sterile solution contains ondansetron hydrochloride dihydrate and inactive ingredients. Manufactured by West-Ward, distributed by Cardinal Health.*
FDA Label Image

Structural Formula (Ondansetron Injection Usp Novaplus 1)

Structural Formula (Ondansetron Injection Usp   Novaplus 1)
Chemical structure showing the molecular formula of Ondansetron hydrochloride dihydrate, the active ingredient in Ondansetron injection 2 mg/mL by Cardinal Health 107, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.